NSE · AI Signal & Stock Analysis · Neutral
As of Sep 28 2026, 6:47 PM, AkshayaAI's signal for BLISSGVS is Neutral → (moderate move); technical trend raise-2026-08-11; trading at ₹671.00 (+4.95% today); overbought (RSI 79).
Data as of Sep 28 2026, 6:47 PM. Informational analytics only — not investment advice.
| AI signal | Neutral → · Moderate move |
|---|---|
| Technical trend | RAISE-2026-08-11 |
| Price | ₹671.00 |
| Change today | +4.95% |
| RSI (14) | 79.10 |
| Relative volume | 0.25 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | ₹7,844 Cr |
| P/E | 55.88 |
| Cap category | Mid Cap |
| 52-week high | 0.0% away |
| 52-week low | +426.8% above |
| Delivery volume | — |
| Sector | Drug Manufacturers - Specialty & Generic |
As of Sep 28 2026, 6:47 PM, AkshayaAI's signal for BLISSGVS (Bliss GVS Pharma Limited) is Neutral with a moderate move, and its technical trend is raise-2026-08-11. The composite score and full factor breakdown are available to signed-in members.
BLISSGVS's RSI is overbought (RSI 79). A reading above 70 is typically overbought and below 30 oversold.
BLISSGVS is trading about 0% below its 52-week high and 427% above its 52-week low as of Sep 28 2026, 6:47 PM.
BLISSGVS's market capitalisation is ₹7,844 Cr as of Sep 28 2026, 6:47 PM.
BLISSGVS is classified under Drug Manufacturers - Specialty & Generic in AkshayaAI's taxonomy.
AkshayaAI refreshes its signals daily. The figures on this page are timestamped as of the latest run shown above.
No. AkshayaAI provides informational, AI-generated analytics for BLISSGVS — not personalised investment advice. Always do your own research.
AARTIPHARM · ABBOTINDIA · AJANTPHARM · AKUMS · ALIVUS · ALKEM
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Sep 28 2026, 6:47 PM and may not reflect real-time prices. Always do your own research. How these signals work →
Instant, data-backed answers — free to try.